Issued shares

SThree: Issue of Shares

Retrieved on: 
Wednesday, May 5, 2021
Corporate finance, Financial economics, Finance, Corporations, Equity securities, Stock market, Corporate law, Issued shares, Common stock, 1P, Public limited company

b"Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nSThree plc announces that today it issued 11,191 new Ordinary shares of 1p each.

Key Points: 
  • b"Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.\nThe issuer is solely responsible for the content of this announcement.\nSThree plc announces that today it issued 11,191 new Ordinary shares of 1p each.
  • For confirmation, the Company's issued capital is now 133,449,863 Ordinary shares of 1p each.\nFollowing this issue, the total number of voting rights in SThree is 133,414,096 ordinary shares of 1p each and there are 35,767 shares held in treasury.\n"

DGAP-News: BP p.l.c.: Total Voting Rights

Retrieved on: 
Tuesday, May 4, 2021
Corporate finance, Financial markets, Companies, Financial economics, Stock market, Corporate law, BP, Dividend, Treasury stock, Issued shares

b"The issuer is solely responsible for the content of this announcement.\nAs at 30 April 2021, the issued share capital of BP p.l.c.

Key Points: 
  • b"The issuer is solely responsible for the content of this announcement.\nAs at 30 April 2021, the issued share capital of BP p.l.c.
  • These treasury shares are not taken into consideration in relation to the payment of dividends and voting at shareholder meetings.\nThe total number of voting rights in BP p.l.c.
  • This information may be used by shareholders for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, BP p.l.c.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Aftermath Silver Announces Shares for Debt

Retrieved on: 
Friday, April 30, 2021
Stock market, Corporate finance, Equity securities, Corporations, Corporate law, Issued shares, Share, Mandalay, Economy

b'Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Aftermath Silver Ltd. (TSXV: AAG) (OTCQB: AAGFF) (the "Company" or "Aftermath Silver") announces that pursuant to the terms of the previously announced Share Purchase Agreement (the "Agreement") with Mandalay Resources Corporation ("Mandalay"), the Company has elected to settle the required payment of $1,500,000 owing to Mandalay on April 30, 2021 through the issuance of common shares of the Company (the "Debt Settlement").\nPursuant to the Debt Settlement, the Company will issue 2,054,794 common shares of the Company (the "Shares") at a deemed price of $0.73 per Share to Mandalay.

Key Points: 
  • b'Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Aftermath Silver Ltd. (TSXV: AAG) (OTCQB: AAGFF) (the "Company" or "Aftermath Silver") announces that pursuant to the terms of the previously announced Share Purchase Agreement (the "Agreement") with Mandalay Resources Corporation ("Mandalay"), the Company has elected to settle the required payment of $1,500,000 owing to Mandalay on April 30, 2021 through the issuance of common shares of the Company (the "Debt Settlement").\nPursuant to the Debt Settlement, the Company will issue 2,054,794 common shares of the Company (the "Shares") at a deemed price of $0.73 per Share to Mandalay.
  • The issuance of the Shares to Mandalay is subject to the approval of the TSX Venture Exchange.
  • All Shares issued pursuant to the Debt Settlement will be subject to a four month hold period.\nAftermath Silver Ltd is a leading Canadian junior exploration company focused on silver, and aims to deliver shareholder value through the discovery, acquisition and development of quality silver projects in stable jurisdictions.
  • Aftermath has developed a pipeline of projects at various stages of advancement.

CP announces results of director elections; shareholders approve five-for-one share split

Retrieved on: 
Wednesday, April 21, 2021
Stock market, Finance, Financial economics, Money, Stock certificate, Security, Share, Corporate law, Corporate action, Common stock, Issued shares

b'As the shareholders approved the Share Split at the 2021 annual and special meeting of shareholders held earlier today, CP will proceed to file articles of amendment under the Canada Business Corporations Act to effect the Share Split.

Key Points: 
  • b'As the shareholders approved the Share Split at the 2021 annual and special meeting of shareholders held earlier today, CP will proceed to file articles of amendment under the Canada Business Corporations Act to effect the Share Split.
  • A due bill is an entitlement attached to listed securities undergoing a material corporate action, such as the Share Split.
  • In this instance, the entitlement is to the additional common shares issuable as a result of the Share Split.
  • CP will use the direct registration system ("DRS") to electronically register the common shares issued pursuant to the Share Split, rather than issuing physical share certificates.

Bionomics Successfully Completes A$22.9 million Equity Raise

Retrieved on: 
Friday, April 9, 2021
Stock market, Corporate finance, Corporate law, Issued shares

The Entitlement Offer closed at 5.00pm (Adelaide time) on 30 March 2021 and raised approximately A$20.4 million from the offer of approximately 140.9 million new fully paid ordinary shares in Bionomics (New Shares) at the offer price of A$0.145 per New Share.

Key Points: 
  • The Entitlement Offer closed at 5.00pm (Adelaide time) on 30 March 2021 and raised approximately A$20.4 million from the offer of approximately 140.9 million new fully paid ordinary shares in Bionomics (New Shares) at the offer price of A$0.145 per New Share.
  • Applications under the Oversubscription Facility were in excess of the approximately 55.3 million shares or A$8 million shortfall and were scaled back in accordance with the terms of the Entitlement Offer on a pro rata basis.
  • The Concurrent Placement which was made on substantially the same terms as the Entitlement Offer raised approximately A$2.5 million from the offer of approximately 17.2 million new fully paid ordinary shares in Bionomics (New Concurrent Shares) at the offer price of A$0.145 per New Concurrent Share.
  • The New Concurrent Shares issued under the Concurrent Placement were allocated from Bionomics' expanded placement capacity following the Entitlement Offer.

FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CYDY, RIDE, ROOT and VRM

Retrieved on: 
Wednesday, April 7, 2021
Stock market, Corporate taxation in the United States, Limited liability company, Issued shares, Companies, Articles, Corporations

CEDARHURST, N.Y., April 06, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

Key Points: 
  • CEDARHURST, N.Y., April 06, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.
  • Class Period: October 28, 2020 and March 8, 2021, or shares issued pursuant and/or traceable to the October 2020 Initial Public Offering.
  • Shareholders who purchased shares in these companies during the dates listed are encouraged to contact us via the case links above, by calling toll-free at 1-833-835-1495 or by email ([email protected]).
  • Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Eve Sleep plc: Total Voting Rights

Retrieved on: 
Tuesday, April 6, 2021
Financial economics, Corporate finance, Finance, Stock market, Equity securities, Corporations, Corporate law, Common stock, Issued shares, Share

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with the Disclosure Guidance and Transparency Rule 5.6.1, the Company notifies the market of the following: as at 31 March 2021, the total issued share capital of the Company comprised 273,230,525 ordinary shares of 0.1 pence each ("Ordinary Shares") with one voting right per share.
  • The Company does not hold any Ordinary Shares in Treasury.

SThree: Voting Rights and Capital

Retrieved on: 
Thursday, April 1, 2021
Stock market, Corporate finance, Sthree, Issued shares, Corporations, Shareholder, Economy

At the date of this announcement, SThree plc's issued share capital consists of 133,435,165 ordinary shares of 1p each.

Key Points: 
  • At the date of this announcement, SThree plc's issued share capital consists of 133,435,165 ordinary shares of 1p each.
  • Currently there are 35,767 shares held in Treasury, and the total number of voting rights in SThree plc is 133,399,398.
  • Shareholders may use the above figure of 133,399,398 as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change in their interest in, SThree plc under the FCA's Disclosure and Transparency Rules.

Travis Perkins: Total Voting Rights

Retrieved on: 
Thursday, April 1, 2021
Financial markets, Corporate finance, Financial economics, Finance, Stock market, Equity securities, Corporate law, Issued shares, Common stock, Share capital, Share, Treasury stock

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

Total Voting Rights

Retrieved on: 
Thursday, April 1, 2021
Corporate finance, Corporate law, Financial economics, Corporations, Finance, Stock market, Equity securities, Issued shares, Common stock, Share capital

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with 5.6.1R of the Disclosure Guidance and Transparency Rules, Arix Bioscience plc announces that its total issued share capital at the close of business on 31 March 2021 comprised 135,609,653 Ordinary Shares of 0.001 pence each fully paid.
  • This figure includes 629,000 Ordinary Shares which are held in Treasury, leaving a balance of 134,980,653 Ordinary Shares with voting rights.